Noninvasive assessment of radiation-induced renal injury in mice.


Journal

International journal of radiation biology
ISSN: 1362-3095
Titre abrégé: Int J Radiat Biol
Pays: England
ID NLM: 8809243

Informations de publication

Date de publication:
2021
Historique:
pubmed: 20 1 2021
medline: 23 9 2021
entrez: 19 1 2021
Statut: ppublish

Résumé

The kidney is a radiosensitive late-responding normal tissue. Injury is characterized by radiation nephropathy and decline of glomerular filtration rate (GFR). The current study aimed to compare two rapid and cost-effective methodologies of assessing GFR against more conventional biomarker measurements. C57BL/6 mice were treated with bilateral focal X-irradiation (1x14Gy or 5x6Gy). Functional measurements of kidney injury were assessed 20 weeks post-treatment. GFR was estimated using a transcutaneous measurement of fluorescein-isothiocyanate conjugated (FITC)-sinistrin renal excretion and also dynamic contrast-enhanced CT imaging with a contrast agent (ISOVUE-300 Iopamidol). Hematoxylin and eosin (H&E) and Periodic acid-Schiff staining identified comparable radiation-induced glomerular atrophy and mesangial matrix accumulation after both radiation schedules, respectively, although the fractionated regimen resulted in less diffuse tubulointerstitial fibrosis. Albumin-to-creatinine ratios (ACR) increased after irradiation (1x14Gy: 100.4 ± 12.2 µg/mg; 6x5Gy: 80.4 ± 3.02 µg/mg) and were double that of nontreated controls (44.9 ± 3.64 µg/mg). GFR defined by both techniques was negatively correlated with BUN, mesangial expansion score, and serum creatinine. The FITC-sinistrin transcutaneous method was more rapid and can be used to assess GFR in conscious animals, dynamic contrast-enhanced CT imaging technique was equally safe and effective. This study demonstrated that GFR measured by dynamic contrast-enhanced CT imaging is safe and effective compared to transcutaneous methodology to estimate kidney function.

Identifiants

pubmed: 33464992
doi: 10.1080/09553002.2021.1876950
pmc: PMC8352084
mid: NIHMS1722610
doi:

Substances chimiques

Creatinine AYI8EX34EU

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

664-674

Subventions

Organisme : NCI NIH HHS
ID : R01 CA227493
Pays : United States

Références

J Clin Oncol. 2011 Jun 10;29(17):2416-23
pubmed: 21555692
Br J Radiol. 1986 Jun;59(702):587-95
pubmed: 3708268
Nephrol Dial Transplant. 2009 Oct;24(10):2997-3001
pubmed: 19461009
PLoS One. 2013 Nov 18;8(11):e79992
pubmed: 24260332
Nephron. 1993;64(4):626-35
pubmed: 8366991
J Vis Exp. 2018 Oct 21;(140):
pubmed: 30394397
Nucl Med Biol. 2014 Feb;41(2):210-5
pubmed: 24388044
Clin J Am Soc Nephrol. 2012 Sep;7(9):1416-27
pubmed: 22822016
J Pharmacol Toxicol Methods. 2013 May-Jun;67(3):187-93
pubmed: 23376812
Cell Biol Int. 1996 Jan;20(1):15-27
pubmed: 8936403
Nephron. 1998 Aug;79(4):408-12
pubmed: 9689155
Nat Med. 2011 Jul 31;17(8):952-60
pubmed: 21804539
Kidney Int Suppl. 2010 Dec;(119):S22-6
pubmed: 21116313
Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1436-43
pubmed: 18355974
Int J Radiat Oncol Biol Phys. 1995 Mar 30;31(5):1249-56
pubmed: 7713786
Clin Physiol. 1985 Feb;5(1):1-17
pubmed: 3882316
Radiat Oncol. 2014 Nov 26;9:253
pubmed: 25424613
Am J Physiol Renal Physiol. 2012 Sep;303(5):F783-8
pubmed: 22696603
J Transl Med. 2013 Jan 15;11:17
pubmed: 23320604
Semin Oncol. 2013 Dec;40(6):757-73
pubmed: 24331195
Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):810-21
pubmed: 12095546
Semin Nephrol. 2010 Nov;30(6):627-34
pubmed: 21146127
Kidney Int Suppl (2011). 2014 Nov;4(1):9-15
pubmed: 26312144
Oncotarget. 2016 Apr 5;7(14):18825-36
pubmed: 26958942
Nephrology (Carlton). 2015 Mar;20(3):117-23
pubmed: 25388805
Semin Radiat Oncol. 2007 Apr;17(2):81-8
pubmed: 17395038
Eur J Cancer. 1993;29A(16):2239-43
pubmed: 8110493
J Clin Invest. 2009 Apr;119(4):943-53
pubmed: 19287096
Am J Physiol. 1986 Dec;251(6 Pt 2):H1324-32
pubmed: 3789184
FASEB J. 2017 Feb;31(2):771-780
pubmed: 27836988
Cochrane Database Syst Rev. 2013 Oct 08;(10):CD008944
pubmed: 24101439
Q J Med. 1953 Apr;22(86):215-42
pubmed: 13056165
Int J Radiat Oncol Biol Phys. 1991 May 15;21(1):109-22
pubmed: 2032882
Radiother Oncol. 1991 Aug;21(4):277-81
pubmed: 1924867
FASEB J. 2020 Jun;34(6):7915-7926
pubmed: 32293077
Curr Radiopharm. 2015;8(1):49-55
pubmed: 25506705
Radiother Oncol. 2013 Sep;108(3):464-8
pubmed: 23849167
Int J Radiat Oncol Biol Phys. 1988 Apr;14(4):751-9
pubmed: 3350731
Med Phys. 2017 Sep;44(9):4786-4794
pubmed: 28627007
J Nucl Med. 2010 Jul;51(7):1049-58
pubmed: 20554737
Int J Radiat Biol. 1989 Oct;56(4):449-62
pubmed: 2571658
PLoS One. 2013 Aug 19;8(8):e71519
pubmed: 23977062
Kidney Int. 2007 Feb;71(3):266-71
pubmed: 17149371
Med Phys. 2017 Sep;44(9):4795-4803
pubmed: 28626876
Kidney Int. 2011 Jun;79(11):1254-8
pubmed: 21368744
Nucl Med Commun. 2007 Jul;28(7):547-53
pubmed: 17538396
Cancer. 2007 Sep 15;110(6):1376-84
pubmed: 17634949
Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266
pubmed: 11904577
Nat Rev Nephrol. 2009 Aug;5(8):450-62
pubmed: 19564889
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S108-15
pubmed: 20171504
Semin Nephrol. 2003 Sep;23(5):486-99
pubmed: 13680538
Semin Hematol. 2012 Jan;49(1):73-82
pubmed: 22221787

Auteurs

Anis Ahmad (A)

Department of Radiation Oncology, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL, USA.

Junwei Shi (J)

Department of Radiation Oncology, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL, USA.

Saba Ansari (S)

Department of Radiation Oncology, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL, USA.

Jumana Afaghani (J)

Department of Radiation Oncology, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL, USA.

Judith Molina (J)

Katz Family Division of Nephrology and Hypertension, Department of Medicine, Peggy and Harold Katz Family Drug Discovery Center, University of Miami, Miami, FL, USA.

Alan Pollack (A)

Department of Radiation Oncology, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL, USA.

Sandra Merscher (S)

Katz Family Division of Nephrology and Hypertension, Department of Medicine, Peggy and Harold Katz Family Drug Discovery Center, University of Miami, Miami, FL, USA.

Youssef H Zeidan (YH)

Department of Radiation Oncology, Anatomy, Cell Biology, and Physiology, American University of Beirut School of Medicine, Beirut, Lebanon.

Alessia Fornoni (A)

Katz Family Division of Nephrology and Hypertension, Department of Medicine, Peggy and Harold Katz Family Drug Discovery Center, University of Miami, Miami, FL, USA.

Brian Marples (B)

Department of Radiation Oncology, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL, USA.
Katz Family Division of Nephrology and Hypertension, Department of Medicine, Peggy and Harold Katz Family Drug Discovery Center, University of Miami, Miami, FL, USA.
Department of Radiation Oncology, University of Rochester, Rochester, NY, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH